These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797 [TBL] [Abstract][Full Text] [Related]
8. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease]. Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627 [TBL] [Abstract][Full Text] [Related]
9. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. Cozzolino M; Dusso AS; Liapis H; Finch J; Lu Y; Burke SK; Slatopolsky E J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974 [TBL] [Abstract][Full Text] [Related]
10. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients. Chudek J; Piecha G; Kokot F; Wiecek A J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418 [TBL] [Abstract][Full Text] [Related]
11. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849 [TBL] [Abstract][Full Text] [Related]
12. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure. Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210 [TBL] [Abstract][Full Text] [Related]
14. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sevelamer. Comparison with calcium carbonate in the treatment of hyperphosphatemia in hemodialysis patients. Shaheen FA; Akeel NM; Badawi LS; Souqiyyeh MZ Saudi Med J; 2004 Jun; 25(6):785-91. PubMed ID: 15195212 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients. Burke SK; Dillon MA; Hemken DE; Rezabek MS; Balwit JM Adv Ren Replace Ther; 2003 Apr; 10(2):133-45. PubMed ID: 12879374 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders. Sturtevant JM; Hawley CM; Reiger K; Johnson DW; Campbell SB; Burke JR; Bofinger A; Isbel NM Nephrology (Carlton); 2004 Dec; 9(6):406-13. PubMed ID: 15663645 [TBL] [Abstract][Full Text] [Related]
18. Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients. Gallieni M; Cozzolino M; Carpani P; Zoni U; Brancaccio D J Nephrol; 2001; 14(3):176-83. PubMed ID: 11439741 [TBL] [Abstract][Full Text] [Related]
19. Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure. Eto N; Miyata Y; Ohno H; Yamashita T Nephrol Dial Transplant; 2005 Jul; 20(7):1378-84. PubMed ID: 15870221 [TBL] [Abstract][Full Text] [Related]
20. Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial. Chertow GM; Dillon MA; Amin N; Burke SK J Ren Nutr; 2000 Jul; 10(3):125-32. PubMed ID: 10921533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]